The end of disease? The mind-boggling potential of AI for transformative change. What should we be telling kids to study now? Millions of jobs might not exist in ten years’ time, and for once, it’s not the back-breaking physical jobs that will be made obsolete, it’s the

HI PEITHO trial of catheter lysis vs anticoag in Int-High Risk PE crosses 500 mark. 544 and we are done. Thank you to all the investigators in this landmark trial for their superb efforts.

Doctors order CTs for every minor head bump, not because it's good medicine, but because it’s legally safe. Missing a trivial brain bleed? Career-ending. But irradiating 20 people to find one? No lawsuit. No friction. No second thought. Yet this new UC San Francisco study shows that

World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group Univ.-Prof. Dr. Ralph Stephan von Bardeleben AGIK Deutsche Gesellschaft für Kardiologie Edoardo Zancanaro MD Erik Rafflenbeul European Society of Cardiology Journals Holger Thiele

New administration has gone too far now.

Beautiful study by Alex Leung, MD MPH et al. Hopefully this will keep the momentum going for simplifying PA diagnosis and or empiric MR antagonist thearpy. acpjournals.org/doi/10.7326/AN…

A low-salt diet confers no additional effect on blood pressure when hypertensive patients are already being treated with a thiazide diuretic. ahajournals.org/doi/full/10.11…

𝐃𝐒𝐄 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐬 𝐢𝐧 𝐎𝐑𝐁𝐈𝐓𝐀-𝟐: Stress echo ischemia identifies who 𝘳𝘦𝘢𝘭𝘭𝘺 benefits from PCI. 📖 𝐉𝐮𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐢𝐧 #𝐉𝐀𝐂𝐂: bit.ly/42PNCcB Rasha Al-Lamee Matthew Shun-Shin Christopher Rajkumar Michael Foley Florentina Simader Shayna Chotai

Very important international perspectives captured by TCTMD: Should we be looking for 'Occlusion MI' rather than STEMI? An excellent interview with expert cardiologists and emergency physicians discussing the need for a new paradigm!

🔥#EuroPCR 2025 Major Late-Breaking Trials results: Angiography versus physiology-guided PCI in patients undergoing TAVI FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI,

Sincere thanks from the Penumbra team to Andrew SP Sharp , chief, Salvatore Brugaletta, Juan F. Iglesias for an insightful symposium on "Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS,"! #Cardiology #ACSMgmt #ThrombusRemoval #Penumbra

Day 2 at #EuroPCR 2025 was insightful! In our #PulmonaryEmbolism session Andrew SP Sharp discussed ultrasound's effect on clots and EKOS for severe PE. Later, Dan Blackman led a #TAVI panel on CEP and ACURATE. We also had a packed Training Village and a #WomenInCardiology session

PE gold at #EuroPCR from ⁦Catalin Toma, MD⁩

Supra-annular valves looking pretty good in particular.